| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_893aafdeeab700ce33f67077d078aa73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324d1bdfc533d6aab178d6c774b389e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7a7939ebf57f1e912a64029f3da96e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 |
| filingDate |
1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c2bfaab4fd65318cc8ea44969d7d7a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f566a338e1446420e84538f2893654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea43384fc04da643549a83898dbfa89c |
| publicationDate |
1998-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9843966-A1 |
| titleOfInvention |
Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
| abstract |
The invention encompasses the novel compound of Formula (I) as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8536348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0014082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022195579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023150719-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6180651-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7956088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188145-B2 |
| priorityDate |
1997-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |